|
1
|
Balkwill FR, Capasso M and Hagemann T: The
tumor microenvironment at a glance. J Cell Sci. 125:5591–5596.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frantz C, Stewart KM and Weaver VM: The
extracellular matrix at a glance. J Cell Sci. 123:4195–4200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mason SD and Joyce JA: Proteolytic
networks in cancer. Trends Cell Biol. 21:228–237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Naba A, Clauser KR, Whittaker CA, Carr SA,
Tanabe KK and Hynes RO: Extracellular matrix signatures of human
primary metastatic colon cancers and their metastases to liver. BMC
Cancer. 14:5182014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barascuk N, Veidal SS, Larsen L, Larsen
DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM and
Karsdal MA: A novel assay for extracellular matrix remodeling
associated with liver fibrosis: An enzyme-linked immunosorbent
assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of
type III collagen. Clin Biochem. 43:899–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hilska M, Collan Y, Peltonen J, Gullichsen
R, Paajanen H and Laato M: The distribution of collagen types I,
III, and IV in normal and malignant colorectal mucosa. Eur J Surg.
164:457–464. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karsdal MA, Nielsen MJ, Sand JM, Henriksen
K, Genovese F, Bay-Jensen AC, Smith V, Adamkewicz JI, Christiansen
C and Leeming DJ: Extracellular matrix remodeling: The common
denominator in connective tissue diseases. Possibilities for
evaluation and current understanding of the matrix as more than a
passive architecture, but a key player in tissue failure. Assay
Drug Dev Technol. 11:70–92. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vassiliadis E, Oliveira CP,
Alvares-da-Silva MR, Zhang C, Carrilho FJ, Stefano JT, Rabelo F,
Pereira L, Kappel CR, Henriksen K, et al: Circulating levels of
citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis
related pathology. Am J Transl Res. 4:403–414. 2012.PubMed/NCBI
|
|
10
|
Mor-Vaknin N, Punturieri A, Sitwala K and
Markovitz DM: Vimentin is secreted by activated macrophages. Nat
Cell Biol. 5:59–63. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ngan CY, Yamamoto H, Seshimo I, Tsujino T,
Man-i M, Ikeda JI, Konishi K, Takemasa I, Ikeda M, Sekimoto M, et
al: Quantitative evaluation of vimentin expression in tumour stroma
of colorectal cancer. Br J Cancer. 96:986–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steinmetz NF, Cho CF, Ablack A, Lewis JD
and Manchester M: Cowpea mosaic virus nanoparticles target surface
vimentin on cancer cells. Nanomedicine (Lond). 6:351–364. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gudmann NS, Hansen NU, Jensen AC, Karsdal
MA and Siebuhr AS: Biological relevance of citrullinations:
Diagnostic, prognostic and therapeutic options. Autoimmunity.
48:73–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mortensen JH, Godskesen LE, Jensen MD, Van
Haaften WT, Klinge LG, Olinga P, Dijkstra G, Kjeldsen J, Karsdal
MA, Bay-Jensen AC and Krag A: Fragments of citrullinated and
MMP-degraded Vimentin and MMP-degraded type III collagen are novel
serological biomarkers to differentiate crohn's disease from
ulcerative colitis. J Crohns Colitis. 9:863–872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Willumsen N, Bager CL, Leeming DJ, Smith
V, Karsdal MA, Dornan D and Bay-Jensen AC: Extracellular matrix
specific protein fingerprints measured in serum can seperate
pancreatic cancer patients from healthy controls. BMC Cancer.
13:5542013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bager CL, Willumsen N, Leeming DJ, Smith
V, Karsdal MA, Dornan D and Bay-Jensen AC: Collagen degradation
products measured in serum can separate ovarian and breast cancer
patients from healthy controls: A preliminary study. Cancer
Biomark. 15:783–788. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Willumsen N, Bager CL, Leeming DJ, Smith
V, Christiansen C, Karsdal MA, Dornan D and Bay-Jensen AC: Serum
biomarkers reflecting specific tumor tissue remodeling processes
are valuable diagnostic tools for lung cancer. Cancer Med.
3:1136–1145. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pirnia F, Frese S, Gloor B, Hotz MA,
Luethi A, Gugger M, Betticher DC and Borner MM: Ex vivo assessment
of chemotherapy-induced apoptosis and associated molecular changes
in patient tumor samples. Anticancer Res. 26:1765–1772.
2006.PubMed/NCBI
|
|
19
|
Freeman AE and Hoffman RM: In vivo-like
growth of human tumors in vitro. Proc Natl Acad Sci USA.
83:2694–2698. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pickup MW, Mouw JK and Weaver VM: The
extracellular matrix modulates the hallmarks of cancer. EMBO Rep.
15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karsdal MA, Delvin E and Christiansen C:
Protein fingerprints-relying on and understanding the information
of serological protein measurements. Clin Biochem. 44:1278–1279.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herszényi L, Barabás L, Hritz I, István G
and Tulassay Z: Impact of proteolytic enzymes in colorectal cancer
development and progression. World J Gastroenterol. 20:13246–13257.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Langers AM, Verspaget HW, Hawinkels LJ,
Kubben FJ, van Duijn W, van der Reijden JJ, Hardwick JC, Hommes DW
and Sier CF: MMP-2 and MMP-9 in normal mucosa are independently
associated with outcome of colorectal cancer patients. Br J Cancer.
106:1495–1498. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edelstein PS, Thompson SM and Davies RJ:
Altered intracellular calcium regulation in human colorectal
cancers and in ‘normal’ adjacent mucosa. Cancer Res. 51:4492–4494.
1991.PubMed/NCBI
|
|
26
|
Kehlet SN, Sanz-Pamplona R, Brix S,
Leeming DJ, Karsdal MA and Moreno V: Excessive collagen turnover
products are released during colorectal cancer progression and
elevated in serum from metastatic colorectal cancer patients. Sci
Rep. 6:305992016. View Article : Google Scholar : PubMed/NCBI
|
